D-1168-2017 Class II Terminated

Recalled by Pfizer Inc. — New York, NY

Recall Details

Product Type
Drugs
Report Date
September 27, 2017
Initiation Date
August 22, 2017
Termination Date
February 19, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
98,050 vials

Product Description

Levophed (norepinephrine bitartrate) injection, USP, 4 mg/4 mL (1mg/mL), 4mL Fill in 5 mL Single dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3375-04

Reason for Recall

Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.

Distribution Pattern

United States Nationwide (including Puerto Rico) and Singapore

Code Information

Lot #: 753003A, Exp 9/18; 762153A, 760803A, 761053A , Exp 10/18